The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy
Open accessAbstract
// Xiang Zheng 1 , Kati Turkowski 1 , Javier Mora 2 , Bernhard Brüne 2 , Werner Seeger 1, 3 , Andreas Weigert 2 and Rajkumar Savai 1, 3 1 Max Planck Institute for Heart and Lung Research, Department of Lung Development and Remodeling, Member of the German Center for Lung Research (DZL), Bad Nauheim, Germany 2 Institute of Biochemistry I, Goethe-University Frankfurt, Frankfurt, Germany 3 Department of Internal Medicine, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the DZL, Justus Liebig University, Giessen, Germany Correspondence to: Rajkumar Savai, email: rajkumar.savai@mpi-bn.mpg.de Andreas Weigert, email: weigert@biochem.uni-frankfurt.de Keywords: tumor microenvironment, macrophages, repolarization, cancer progression, metastasis Received: October 15, 2016 Accepted: March 22, 2017 Published: April 12, 2017 ABSTRACT Cancer research in recent decades has highlighted the potential influence of the tumor microenvironment on the progression and metastasis of most known cancer types. Within the established microenvironment, tumor-associated macrophages (TAMs) are one of the most abundant and crucial non-neoplastic cell types. The polarization of macrophages into tumor-suppressive M1 or tumor-promoting M2 types is a fundamental event in the establishment of the tumor microenvironment. Although ample evidence indicates that TAMs are primarily M2 polarized, the mechanisms responsible for the regulation and maintenance of M1 and M2 polarization imbalance remain unclear. The manipulation of this critical axis through three main approaches may provide new strategies for cancer therapy — (I) specific interference with M2-like TAM survival or inhibiting their signaling cascades, (II) repression of macrophage recruitment to tumors, and (III) repolarization of tumor-promoting M2-like TAMs to a tumoricidal M1-like phenotype. This review summarizes current strategies for cancer intervention via manipulation of macrophage polarization, with particular focus on composition of the tumor microenvironment and its influence on cancer progression and metastasis. It is clear that additional fundamental and preclinical research is required to confirm the efficacy and practicality of this novel and promising strategy for treating cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190 · cited 3×
“In contrast to embryonic macrophages, bone marrow–derived macrophages are usually short-lived, rarely proliferate and are continuously replaced [27, 29].”
BackgroundMacrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684 · cited 6×
“They command a broad sensory arsenal to detect perturbations in tissue integrity and possess a remarkable functional plasticity to combat diseases [27].”
BackgroundInfluentialMacrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., De Nardo, D., Gohel, T. D., Emde, M., Schmidleithner, L., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.006 · Cited by 2,210
Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment
Lavin, Y., Winter, D., Blecher-Gonen, R., David, E., Keren-Shaul, H., Merad, M., Jung, S., & Amit, I. (2014) · Cell · doi:10.1016/j.cell.2014.11.018 · Cited by 2,167
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Beatty, G. L., Chiorean, E. G., Fishman, M. P., Saboury, B., Teitelbaum, U. R., Sun, W., Huhn, R. D., Song, W., Li, D., Sharp, L. L., et al. (2011) · Science · doi:10.1126/science.1198443 · Cited by 1,672
The cellular and molecular origin of tumor-associated macrophages
Franklin, R. A., Liao, W., Sarkar, A., Kim, M. V., Bivona, M. R., Liu, K., Pamer, E. G., & Li, M. O. (2014) · Science · doi:10.1126/science.1252510 · Cited by 1,393
Ries, C. H., Cannarile, M. A., Hoves, S., Benz, J., Wartha, K., Runza, V., Rey-Giraud, F., Pradel, L. P., Feuerhake, F., Klaman, I., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.016 · Cited by 1,384
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Malam, Y., Loizidou, M., & Seifalian, A. M. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.004 · Cited by 1,318
Movahedi, K., Laoui, D., Gysemans, C., Baeten, M., Stangé, G., Van den Bossche, J., Mack, M., Pipeleers, D., In't Veld, P., De Baetselier, P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4672 · Cited by 1,239
Cancer immunotherapy: the beginning of the end of cancer?
Farkona, S., Diamandis, E. P., & Blasutig, I. M. (2016) · BMC Medicine · doi:10.1186/s12916-016-0623-5 · Cited by 1,184
Satoh, T., Takeuchi, O., Vandenbon, A., Yasuda, K., Tanaka, Y., Kumagai, Y., Miyake, T., Matsushita, K., Okazaki, T., Saitoh, T., et al. (2010) · Nature Immunology · doi:10.1038/ni.1920 · Cited by 1,156
Direct Visualization of Macrophage-Assisted Tumor Cell Intravasation in Mammary Tumors
Wyckoff, J. B., Wang, Y., Lin, E. Y., Li, J.-F., Goswami, S., Stanley, E. R., Segall, J. E., Pollard, J. W., & Condeelis, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1823 · Cited by 1,053
Ruffell, B., Chang-Strachan, D., Chan, V., Rosenbusch, A., Ho, C. M. T., Pryer, N., Daniel, D., Hwang, E. S., Rugo, H. S., & Coussens, L. M. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.006 · Cited by 1,008
Stout, R. D., Jiang, C., Matta, B., Tietzel, I., Watkins, S. K., & Suttles, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.342 · Cited by 968
Mitchem, J. B., Brennan, D. J., Knolhoff, B. L., Belt, B. A., Zhu, Y., Sanford, D. E., Belaygorod, L., Carpenter, D., Collins, L., Piwnica-Worms, D., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2731 · Cited by 943
Specification of tissue-resident macrophages during organogenesis
Mass, E., Ballesteros, I., Farlik, M., Halbritter, F., Günther, P., Crozet, L., Jacome-Galarza, C. E., Händler, K., Klughammer, J., Kobayashi, Y., et al. (2016) · Science · doi:10.1126/science.aaf4238 · Cited by 891
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
Germano, G., Frapolli, R., Belgiovine, C., Anselmo, A., Pesce, S., Liguori, M., Erba, E., Uboldi, S., Zucchetti, M., Pasqualini, F., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.008 · Cited by 864
miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice
Boldin, M. P., Taganov, K. D., Rao, D. S., Yang, L., Zhao, J. L., Kalwani, M., Garcia-Flores, Y., Luong, M., Devrekanli, A., Xu, J., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101823 · Cited by 861
Sinha, P., Clements, V. K., Bunt, S. K., Albelda, S. M., & Ostrand-Rosenberg, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.977 · Cited by 847
Lindau, D., Gielen, P., Kroesen, M., Wesseling, P., & Adema, G. J. (2013) · Immunology · doi:10.1111/imm.12036 · Cited by 815
Tumor microenvironment: Sanctuary of the devil
Hui, L., & Chen, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.039 · Cited by 779
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma
Kryczek, I., Zou, L., Rodriguez, P., Zhu, G., Wei, S., Mottram, P., Brumlik, M., Cheng, P., Curiel, T., Myers, L., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050930 · Cited by 748
Tumor-associated neutrophils: friend or foe?
Fridlender, Z. G., & Albelda, S. M. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs123 · Cited by 699
Rolny, C., Mazzone, M., Tugues, S., Laoui, D., Johansson, I., Coulon, C., Squadrito, M. L., Segura, I., Li, X., Knevels, E., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.11.009 · Cited by 695 · cited 2×
“Histidine-rich glycoprotein repolarizes M2-like TAMs to enhance anti-tumor immune responses and vessel normalization via downregulation of placental growth factor (PlGF) [77].”
BackgroundThe S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase
Hiratsuka, S., Watanabe, A., Sakurai, Y., Akashi-Takamura, S., Ishibashi, S., Miyake, K., Shibuya, M., Akira, S., Aburatani, H., & Maru, Y. (2008) · Nature Cell Biology · doi:10.1038/ncb1794 · Cited by 642
Casazza, A., Laoui, D., Wenes, M., Rizzolio, S., Bassani, N., Mambretti, M., Deschoemaeker, S., Van Ginderachter, J. A., Tamagnone, L., & Mazzone, M. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.11.007 · Cited by 629
Zeisberger, S. M., Odermatt, B., Marty, C., Zehnder-Fjällman, A. H. M., Ballmer-Hofer, K., & Schwendener, R. A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603240 · Cited by 623
Sanford, D. E., Belt, B. A., Panni, R. Z., Mayer, A., Deshpande, A. D., Carpenter, D., Mitchem, J. B., Plambeck-Suess, S. M., Worley, L. A., Goetz, B. D., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0525 · Cited by 613
Ahsan, F. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00549-1 · Cited by 570
Targeting tumor-associated macrophages as a novel strategy against breast cancer
Luo, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27648 · Cited by 552
Guiducci, C., Vicari, A. P., Sangaletti, S., Trinchieri, G., & Colombo, M. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4262 · Cited by 549
Wang, J., & Kubes, P. (2016) · Cell · doi:10.1016/j.cell.2016.03.009 · Cited by 537
Comito, G., Giannoni, E., Segura, C. P., Barcellos-de-Souza, P., Raspollini, M. R., Baroni, G., Lanciotti, M., Serni, S., & Chiarugi, P. (2014) · Oncogene · doi:10.1038/onc.2013.191 · Cited by 528
Liu, C.-Y., Xu, J.-Y., Shi, X.-Y., Huang, W., Ruan, T.-Y., Xie, P., & Ding, J.-L. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.69 · Cited by 465
Ma, J., Liu, L., Che, G., Yu, N., Dai, F., & You, Z. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-112 · Cited by 437
Targeted Liposomal Drug Delivery to Monocytes and Macrophages
Kelly, C., Jefferies, C., & Cryan, S.-A. (2011) · Journal of Drug Delivery · doi:10.1155/2011/727241 · Cited by 425
Queen, M. M., Ryan, R. E., Holzer, R. G., Keller-Peck, C. R., & Jorcyk, C. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1734 · Cited by 413
Martinez-Outschoorn, U. E., Trimmer, C., Lin, Z., Whitaker-Menezes, D., Chiavarina, B., Zhou, J., Wang, C., Pavlides, S., Martinez-Cantarin, M. P., Capozza, F., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.17.12928 · Cited by 408
Puig-Kröger, A., Sierra-Filardi, E., Domínguez-Soto, A., Samaniego, R., Corcuera, M. T., Gómez-Aguado, F., Ratnam, M., Sánchez-Mateos, P., & Corbí, A. L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2050 · Cited by 389
Cancer immunoediting by the innate immune system in the absence of adaptive immunity
O’Sullivan, T., Saddawi-Konefka, R., Vermi, W., Koebel, C. M., Arthur, C., White, J. M., Uppaluri, R., Andrews, D. M., Ngiow, S. F., Teng, M. W. L., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112738 · Cited by 348
Umemura, N., Saio, M., Suwa, T., Kitoh, Y., Bai, J., Nonaka, K., Ouyang, G.-F., Okada, M., Balazs, M., Adany, R., et al. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0907611 · Cited by 346
Loberg, R. D., Ying, C., Craig, M., Day, L. L., Sargent, E., Neeley, C., Wojno, K., Snyder, L. A., Yan, L., & Pienta, K. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1286 · Cited by 333
Duluc, D., Corvaisier, M., Blanchard, S., Catala, L., Descamps, P., Gamelin, E., Ponsoda, S., Delneste, Y., Hebbar, M., & Jeannin, P. (2009) · International Journal of Cancer · doi:10.1002/ijc.24401 · Cited by 329
Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation
Mullican, S. E., Gaddis, C. A., Alenghat, T., Nair, M. G., Giacomin, P. R., Everett, L. J., Feng, D., Steger, D. J., Schug, J., Artis, D., et al. (2011) · Genes & Development · doi:10.1101/gad.175950.111 · Cited by 314
Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival
Cieslewicz, M., Tang, J., Yu, J. L., Cao, H., Zavaljevski, M., Motoyama, K., Lieber, A., Raines, E. W., & Pun, S. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312197110 · Cited by 314
Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions
Laoui, D., Movahedi, K., Van Overmeire, E., Van den Bossche, J., Schouppe, E., Mommer, C., Nikolaou, A., Morias, Y., De Baetselier, P., & Van Ginderachter, J. A. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.113371dl · Cited by 304
Gazzaniga, S., Bravo, A. I., Guglielmotti, A., van Rooijen, N., Maschi, F., Vecchi, A., Mantovani, A., Mordoh, J., & Wainstok, R. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700827 · Cited by 302
Aharinejad, S., Paulus, P., Sioud, M., Hofmann, M., Zins, K., Schäfer, R., Stanley, E. R., & Abraham, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0961 · Cited by 281
Coscia, M., Quaglino, E., Iezzi, M., Curcio, C., Pantaleoni, F., Riganti, C., Holen, I., Mönkkönen, H., Boccadoro, M., Forni, G., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00926.x · Cited by 275
Reinartz, S., Schumann, T., Finkernagel, F., Wortmann, A., Jansen, J. M., Meissner, W., Krause, M., Schwörer, A., Wagner, U., Müller‐Brüsselbach, S., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28335 · Cited by 271
Helm, O., Held‐Feindt, J., Grage‐Griebenow, E., Reiling, N., Ungefroren, H., Vogel, I., Krüger, U., Becker, T., Ebsen, M., Röcken, C., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28736 · Cited by 260
Re-polarization of tumor-associated macrophages to pro-inflammatory M1 macrophages by microRNA-155
Cai, X., Yin, Y., Li, N., Zhu, D., Zhang, J., Zhang, C.-Y., & Zen, K. (2012) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjs044 · Cited by 260
Paulus, P., Stanley, E. R., Schäfer, R., Abraham, D., & Aharinejad, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3523 · Cited by 231
Deng, L., Zhou, J.-F., Sellers, R. S., Li, J.-F., Nguyen, A. V., Wang, Y., Orlofsky, A., Liu, Q., Hume, D. A., Pollard, J. W., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090622 · Cited by 228
Van Overmeire, E., Stijlemans, B., Heymann, F., Keirsse, J., Morias, Y., Elkrim, Y., Brys, L., Abels, C., Lahmar, Q., Ergen, C., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-0869 · Cited by 227
Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors
Shime, H., Matsumoto, M., Oshiumi, H., Tanaka, S., Nakane, A., Iwakura, Y., Tahara, H., Inoue, N., & Seya, T. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113099109 · Cited by 224
Impacts of Salmon on Riparian Plant Diversity
Hocking, M. D., & Reynolds, J. D. (2011) · Science · doi:10.1126/science.1201079 · Cited by 223
miR-511-3p Modulates Genetic Programs of Tumor-Associated Macrophages
Squadrito, M. L., Pucci, F., Magri, L., Moi, D., Gilfillan, G. D., Ranghetti, A., Casazza, A., Mazzone, M., Lyle, R., Naldini, L., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2011.12.005 · Cited by 206
Downey, C. M., Aghaei, M., Schwendener, R. A., & Jirik, F. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099988 · Cited by 193
MicroRNA-mediated control of macrophages and its implications for cancer
Squadrito, M. L., Etzrodt, M., De Palma, M., & Pittet, M. J. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.02.003 · Cited by 187
Hyaluronan Deficiency in Tumor Stroma Impairs Macrophage Trafficking and Tumor Neovascularization
Kobayashi, N., Miyoshi, S., Mikami, T., Koyama, H., Kitazawa, M., Takeoka, M., Sano, K., Amano, J., Isogai, Z., Niida, S., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4687 · Cited by 185
Tracking of intertissue migration reveals the origins of tumor-infiltrating monocytes
Shand, F. H. W., Ueha, S., Otsuji, M., Koid, S. S., Shichino, S., Tsukui, T., Kosugi-Kanaya, M., Abe, J., Tomura, M., Ziogas, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402914111 · Cited by 175
Bacteria in Cancer Therapy: Renaissance of an Old Concept
Felgner, S., Kocijancic, D., Frahm, M., & Weiss, S. (2016) · International Journal of Microbiology · doi:10.1155/2016/8451728 · Cited by 175
Aptamer-Mediated Blockade of IL4Rα Triggers Apoptosis of MDSCs and Limits Tumor Progression
Roth, F., De La Fuente, A. C., Vella, J. L., Zoso, A., Inverardi, L., & Serafini, P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2772 · Cited by 173
Tan, H.-Y., Wang, N., Man, K., Tsao, S., Che, C., & Feng, Y. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.271 · Cited by 162
NF-κB as a central regulator of macrophage function in tumors
Biswas, S. K., & Lewis, C. E. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310153 · Cited by 161
Zhang, X., Tian, W., Cai, X., Wang, X., Dang, W., Tang, H., Cao, H., Wang, L., & Chen, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065896 · Cited by 158
Fujiwara, Y., Komohara, Y., Ikeda, T., & Takeya, M. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01772.x · Cited by 154
The effects of charge and size on the interaction of unilamellar liposomes with macrophages
Schwendener, R. A., Lagocki, P., & Rahman, Y. E. (1984) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(84)90521-2 · Cited by 147
Tumor‐associated fibroblasts recruit blood monocytes into tumor tissue
Silzle, T., Kreutz, M. P., Dobler, M. A., Brockhoff, G., Knuechel, R., & Kunz‐Schughart, L. A. (2003) · European Journal of Immunology · doi:10.1002/eji.200323057 · Cited by 145
Mimura, K., Kono, K., Takahashi, A., Kawaguchi, Y., & Fujii, H. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0234-7 · Cited by 138
Etzerodt, A., Maniecki, M. B., Graversen, J. H., Møller, H. J., Torchilin, V. P., & Moestrup, S. K. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.034 · Cited by 137
Zhang, J., Cao, J., Ma, S., Dong, R., Meng, W., Ying, M., Weng, Q., Chen, Z., Ma, J., Fang, Q., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1856 · Cited by 136
Joshi, S., Singh, A. R., Zulcic, M., & Durden, D. L. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0682 · Cited by 135
Nagai, T., Tanaka, M., Tsuneyoshi, Y., Xu, B., Michie, S. A., Hasui, K., Hirano, H., Arita, K., & Matsuyama, T. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0667-x · Cited by 134
Krneta, T., Gillgrass, A. E., Poznanski, S. M., Chew, M. V., Lee, A. J., Kolb, M. R. J., & Ashkar, A. A. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a1215-552r · Cited by 123
Tymoszuk, P., Evens, H., Marzola, V., Wachowicz, K., Wasmer, M.-H., Datta, S., Müller‐Holzner, E., Fiegl, H., Böck, G., van Rooijen, N., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201344304 · Cited by 111
Alizadeh, D., Zhang, L., Hwang, J., Schluep, T., & Badie, B. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.10.001 · Cited by 103
Chai, Z., Zhu, X., Ao, J., Wang, W., Gao, D., Kong, J., Zhang, N., Zhang, Y., Ye, B., Ma, D.-N., et al. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0150-4 · Cited by 102
The Role of Mast Cells in Molding the Tumor Microenvironment
Rigoni, A., Colombo, M. P., & Pucillo, C. E. M. (2014) · Cancer Microenvironment · doi:10.1007/s12307-014-0152-8 · Cited by 98
Scavenger Receptor-A–Targeted Leukocyte Depletion Inhibits Peritoneal Ovarian Tumor Progression
Bąk, S., Walters, J. J., Takeya, M., Conejo-Garcia, J. R., & Berwin, B. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4410 · Cited by 89
Lizotte, P. H., Baird, J. R., Stevens, C. A., Lauer, P., Green, W. R., Brockstedt, D. G., & Fiering, S. (2014) · OncoImmunology · doi:10.4161/onci.28926 · Cited by 87
Ravi, J., Elbaz, M., Wani, N. A., Nasser, M. W., & Ganju, R. K. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22451 · Cited by 83
Vlaicu, P., Mertins, P., Mayr, T., Widschwendter, P., Ataseven, B., Högel, B., EIERMANN, W., Knyazev, P. G., & Ullrich, A. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-197 · Cited by 80
Khan, M. W., Keshavarzian, A., Gounaris, E. G., Melson, J. E., Cheon, E. C., Blatner, N. R., Chen, Z. E., Tsai, F.-N., Lee, G., Ryu, H., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2623 · Cited by 75
Horlad, H., Fujiwara, Y., Takemura, K., Ohnishi, K., Ikeda, T., Tsukamoto, H., Mizuta, H., Nishimura, Y., Takeya, M., & Komohara, Y. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200610 · Cited by 69
Olesch, C., Sha, W., Angioni, C., Sha, L. K., Açaf, E., Patrignani, P., Jakobsson, P., Radeke, H. H., Grösch, S., Geißlinger, G., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3581 · Cited by 65
Self-citationWang, Q., Cheng, F., Ma, T., Xiong, H.-Y., Li, Z., Xie, C.-L., Liu, C., & Tu, Z. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2687-0 · Cited by 65
Choi, H.-J., Choi, H., Chung, T., & Ha, K. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.002 · Cited by 63
Pulaski, H. L., Spahlinger, G., Silva, I. A., McLean, K., Kueck, A. S., Reynolds, R. K., Coukos, G., Conejo-Garcia, J. R., & Buckanovich, R. J. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-49 · Cited by 62
Gao, J., Wang, D., Liu, D., Liu, M., Ge, Y., Jiang, M., Liu, Y., & Zheng, D. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-04-0209 · Cited by 60
Chakraborty, P., Chatterjee, S., Ganguly, A., Saha, P., Adhikary, A., Das, T., Chatterjee, M., & Choudhuri, S. K. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0611287 · Cited by 41
Banerjee, S., Halder, K., Ghosh, S., Bose, A., & Majumdar, S. (2015) · OncoImmunology · doi:10.1080/2162402x.2014.995559 · Cited by 31
Tsuchiyama, T., Nakamoto, Y., Sakai, Y., Mukaida, N., & Kaneko, S. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00951.x · Cited by 31
Recombinant Mycobacterium bovis BCG for immunotherapy in nonmuscle invasive bladder cancer
Begnini, K. R., Buss, J. H., Collares, T. V., & Seixas, F. K. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6495-3 · Cited by 29
Wang, C., Hu, Z., Zhu, Z., Zhang, X., Wei, Z., Zhang, Y., Hu, D., & Cai, Q. (2015) · Tumor Biology · doi:10.1007/s13277-015-4451-6 · Cited by 27
(2014) · Institutional Repository University of Antioquia (University of Antioquia) · doi:10.1371/journal.pone
Cited by
The Tumor Microenvironment Innately Modulates Cancer Progression
Hinshaw, D. C., & Shevde, L. A. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3962 · Cited by 3,270
Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment
Wu, K., Lin, K., Li, X., Yuan, X., Xu, P., Ni, P., & Xu, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01731 · Cited by 687
Jayasingam, S. D., Citartan, M., Thang, T. H., Mat Zin, A. A., Ang, K. C., & Ch'ng, E. S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01512 · Cited by 635
Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?
Parisi, L., Gini, E., Baci, D., Tremolati, M., Fanuli, M., Bassani, B., Farronato, G., Bruno, A., & Mortara, L. (2018) · Journal of Immunology Research · doi:10.1155/2018/8917804 · Cited by 508
Albini, A., Bruno, A., Noonan, D. M., & Mortara, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00527 · Cited by 392
Metadata
- Authors
- Zheng, X., Turkowski, K., Mora, J., Brüne, B., Seeger, W., Weigert, A., & Savai, R.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2017-04-12
- Volume
- 8
- Issue
- 29
- Pages
- 48436-48452
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2606694952
- Cited by
- 277
- References
- 104
- FWCI
- 12.45
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.